Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Catherine Ramsey Schulte
BAIRD
Catherine Ramsey Schulte
Robert W. Baird
Wall Street Analyst
★★★☆☆
#894
on 13Foresight · ranked by our own returns
67%
Success Rate
+4.2%
Average Return
14 of 21 calls profitable · -0.1% vs benchmark
📈 Across the calls we could measure, roughly 67% of Catherine Ramsey Schulte's ratings turned a profit when each position was held for 1 year — averaging +4.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

51 Buy 19 Hold 0 Sell
Catherine's Stock Coverage 21 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
A
Agilent
 May 26, 2026 BUY Strong Buy
+3.9% avg upside
32 analysts
$156.00
22.68% Upside
 +15.3%
MTD
Mettler-Toledo
 May 11, 2026 HOLD Buy
+2.7% avg upside
18 analysts
$1194.00
4.29% Upside
 +7.0%
CAI
Caris Life Sciences, Inc.
 May 08, 2026 BUY Strong Buy
+54.5% avg upside
20 analysts
$22.00
19.02% Upside
 +2.1%
GH
Guardant Health
 May 08, 2026 BUY Strong Buy
-5.8% avg upside
30 analysts
$129.00
2.21% Downside
 +34.9%
NTRA
Natera
 May 08, 2026 BUY Strong Buy
+7.6% avg upside
26 analysts
$265.00
14.57% Upside
 +16.6%
TECH
Bio-Techne
 May 07, 2026 HOLD Strong Buy
+38.6% avg upside
21 analysts
$49.00
15.38% Downside
 +10.3%
CSTL
Castle Biosciences
 May 07, 2026 BUY Strong Buy
+98.2% avg upside
9 analysts
$43.00
103.57% Upside
 -0.6%
GRAL
GRAIL Inc
 May 06, 2026 BUY Buy
+3.6% avg upside
8 analysts
$70.00
9.85% Upside
 -7.1%
TEM
Tempus AI, Inc. Class A
 May 06, 2026 BUY Strong Buy
+33.8% avg upside
19 analysts
$59.00
16.05% Upside
 -5.5%
WAT
Waters
 May 06, 2026 BUY Strong Buy
+3.5% avg upside
30 analysts
$387.00
8.88% Upside
 +2.4%
TWST
Twist Bioscience
 May 05, 2026 BUY Strong Buy
-25.5% avg upside
14 analysts
$65.00
25.80% Downside
 +49.8%
RVTY
Revvity
 May 04, 2026 BUY Buy
+5.5% avg upside
23 analysts
$117.00
17.07% Upside
 +13.1%
QGEN
Qiagen
 Apr 29, 2026 BUY Buy
+14.1% avg upside
23 analysts
$43.00
16.29% Upside
 -2.5%
TMO
Thermo Fisher
 Apr 24, 2026 BUY Strong Buy
+26.9% avg upside
38 analysts
$639.00
37.44% Upside
 +0.7%
DHR
Danaher
 Apr 22, 2026 BUY Strong Buy
+21.8% avg upside
45 analysts
$245.00
38.21% Upside
 -1.5%
MRVI
Maravai Lifesciences Holdings
 Feb 26, 2026 HOLD Strong Buy
+175.0% avg upside
17 analysts
$3.00
42.37% Downside
 +16.6%
AVTR
Avantor
 Feb 12, 2026 BUY Buy
+49.6% avg upside
26 analysts
$11.00
14.87% Upside
 +5.4%
ILMN
Illumina
 Feb 06, 2026 HOLD Buy
-10.0% avg upside
30 analysts
$137.00
15.34% Downside
 +32.9%
BIORQ
Biora Therapeutics
 Apr 18, 2022 HOLD Strong Buy
+269249900.0% avg upside
6 analysts
 — ·
CVS
CVS Health
 Mar 04, 2019 BUY Strong Buy
+3.1% avg upside
38 analysts
$102.00
3.72% Upside
 +21.9%
CERS
Cerus
 Nov 02, 2018 BUY Strong Buy
+99.1% avg upside
10 analysts
$8.00
196.24% Upside
 -27.2%
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Catherine Ramsey Schulte — Frequently Asked Questions
How accurate are Catherine Ramsey Schulte's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Catherine's ratings were profitable over a one-year hold, with an average return of +4.3% per rating, or -0.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Catherine ranked on 13Foresight?
Catherine Ramsey Schulte is currently ranked #894 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Catherine cover?
Catherine most recently has ratings on A, MTD, CAI, GH, NTRA, TECH, CSTL, GRAL, TEM, WAT, TWST, RVTY and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.